News

With cases of COVID-19 spiking in many areas of the United States, and a greater resurgence expected in the fall, whether and how to reopen schools is the subject of strong national interest.

Clinicians and investigators from Weill Cornell Medicine and NewYork-Presbyterian offer guidance on protecting older adults and building a stronger partnership between the medical and public health systems in two recently published papers on COVID-19.

One method for coronary artery bypass surgery is linked to a significantly lower risk of death, heart attack, or the need for a new surgery compared to the most commonly chosen one, according to an international study led by Weill Cornell Medicine and NewYork-Presbyterian heart surgeons.

Researchers from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center have published guidance on how physicians working on the front lines of the COVID-19 pandemic can compassionately inform family members of the painful news that their loved one has died.

The National Institutes of Health National Heart Lung and Blood Institute has awarded Weill Cornell Medicine investigators $4.2 million to compare quality of life outcomes in patients undergoing two different types of coronary artery bypass graft (CABG) surgery. 

A team of scientists from Weill Cornell Medicine and Texas A&M University has identified a tuberculosis (TB) protein that future drugs might be able to target, with minimal side-effects compared to current treatments—potentially a critical discovery given the global public health crisis of drug-resistant TB.

Hematology and oncology specialist Dr. Jeffrey Laurence answers questions about the connection between blood clotting and other symptoms of severe COVID-19.

COVID-19 patients have a higher risk of stroke than patients with influenza, according to a study from researchers at Weill Cornell Medicine and NewYork-Presbyterian.

Two distinguished Weill Cornell Medicine physician-scientists have been elected to the prestigious Association of American Physicians (AAP). 

Awards, honors, prizes and achievements for the month of June.

An understudied type of liver cell may drive scarring in liver disease and could be a promising target for new treatments, suggests a new study by Weill Cornell Medicine investigators.

An enzyme has been discovered to play a critical role in blocking the metabolic processes that contribute to the rapid growth and spread of liver cancer, according to a new study by Weill Cornell Medicine researchers.

The hormonal shifts that occur with menopause can increase the risk of brain changes associated with Alzheimer’s disease, according to new research from Weill Cornell Medicine investigators.

With COVID-19 limiting resources and presenting logistical challenges for elective treatments, Weill Cornell Medicine and NewYork-Presbyterian clinicians offer guidance on treating cancer in three recently published papers.

When COVID-19 first appeared in NYC hospitals, Weill Cornell Medicine and NewYork-Presbyterian physicians and scientists documented early observations of clinical and pathological characteristics in two publications.

A new technique that involves growing brain tumors in a miniature laboratory model of the human brain recreated the complex genetics of the disease better than other approaches, according to research by investigators at Weill Cornell Medicine and NewYork-Presbyterian.

As the epicenter of the COVID-19 pandemic moves to Latin America and Africa, Weill Cornell Medicine faculty based in Haiti, a country hard hit by natural disasters and poverty, have developed lessons on what low-resourced countries can do to address and treat the outbreak on the ground.

The benefits of the prostate-specific antigen (PSA) test to screen men for prostate cancer may be greater than the harm, say investigators at Weill Cornell Medicine, NewYork-Presbyterian, University of Washington School of Medicine and the Fred Hutchinson Cancer Research Center.

Dr. Kevin Holcomb, a prominent gynecologic oncologist with a longstanding commitment to medical education and leadership, has been named associate dean for admissions at Weill Cornell Medical College, effective July 1. Dr. Jessica Peña, an expert in cardiology and a dedicated mentor of students, residents and fellows, has been appointed to the newly created position of assistant dean for admissions.

Epidemiological models of COVID-19 that are used to guide policies on social distancing measures should take into account the special dynamics of the coronavirus’s spread in nursing homes and other long-term care (LTC) facilities.